[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier for advanced OPTIONS screeners and volatility tools. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Anika Therapeutics (ANIK)

Anika Therapeutics (ANIK)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]] ([[ financialData.relativeStrengthDirection14d ]]) ([[ financialData.highPercent1y ]]) ([[ financialData.lowPercent1y ]])
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 197,594
  • Shares Outstanding, K 13,306
  • Annual Sales, $ 112,820 K
  • Annual Income, $ -10,880 K
  • EBIT $ -11 M
  • EBITDA $ -5 M
  • 60-Month Beta 0.16
  • Price/Sales 1.47
  • Price/Cash Flow N/A
  • Price/Book 1.24

Options Overview Details

View History
  • Implied Volatility 111.75% (+9.95%)
  • Historical Volatility 86.41%
  • IV Percentile 31%
  • IV Rank 20.69%
  • IV High 435.67% on 01/23/26
  • IV Low 27.25% on 09/09/25
  • Expected Move (DTE 11) 0.64 (4.29%)
  • Put/Call Vol Ratio 0.00
  • Today's Volume 32
  • Volume Avg (30-Day) 8
  • Put/Call OI Ratio 0.04
  • Today's Open Interest 426
  • Open Int (30-Day) 410
  • Expected Range 14.21 to 15.49

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 3 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/26
See More
  • Average Estimate $-0.14
  • Number of Estimates 1
  • High Estimate $-0.14
  • Low Estimate $-0.14
  • Prior Year $-0.33
  • Growth Rate Est. (year over year) +57.58%

Price Performance

See More
Period Period Low Period High Performance
1-Month
11.92 +25.00%
on 04/30/26
16.24 -8.25%
on 04/20/26
+0.10 (+0.68%)
since 04/02/26
3-Month
9.88 +50.83%
on 02/13/26
16.24 -8.25%
on 04/20/26
+4.23 (+39.64%)
since 02/04/26
52-Week
7.87 +89.32%
on 07/31/25
16.24 -8.25%
on 04/20/26
+0.05 (+0.34%)
since 05/02/25

Most Recent Stories

More News
TELA Bio Announces Strategic Board Refreshment with Four Highly Experienced Commerical Leaders to Accelerate Growth and Drive Path to Profitability; The Company Also Reports Preliminary First Quarter 2026 Revenues

MALVERN, Pa., April 30, 2026 (GLOBE NEWSWIRE) -- TELA Bio, Inc. (“TELA Bio”), a commercial-stage medical technology company focused on providing innovative soft-tissue reconstruction solutions, today...

AXGN : 42.91 (-0.85%)
TELA : 0.9900 (+0.09%)
ANIK : 14.90 (+0.34%)
MDXG : 3.61 (-1.90%)
ELUT : 1.0100 (unch)
BVS : 10.24 (+1.29%)
Anika: Q1 Earnings Snapshot

Anika: Q1 Earnings Snapshot

ANIK : 14.90 (+0.34%)
Anika Reports First Quarter 2026 Financial Results

Grew total company revenue 13%, driven by Commercial Channel strength and favorable OEM Channel order timing Delivered 64% gross margin, +8 points year over year, driven by improved operational execution...

ANIK : 14.90 (+0.34%)
Xilio Therapeutics Appoints Cheryl R. Blanchard, Ph.D. to its Board of Directors

WALTHAM, Mass., April 16, 2026 (GLOBE NEWSWIRE) -- Xilio Therapeutics, Inc. (Nasdaq: XLO), a clinical-stage biotechnology company discovering and developing masked immuno-oncology therapies for people...

ANIK : 14.90 (+0.34%)
XLO : 8.40 (+0.90%)
Anika to Issue First Quarter 2026 Financial Results on Wednesday, April 29, 2026

BEDFORD, Mass., April 15, 2026 (GLOBE NEWSWIRE) -- Anika Therapeutics, Inc. (NASDAQ: ANIK), a global joint preservation company in early intervention orthopedics, announced today that it will issue...

ANIK : 14.90 (+0.34%)
Anika Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

BEDFORD, Mass., April 03, 2026 (GLOBE NEWSWIRE) -- Anika Therapeutics, Inc. (NASDAQ: ANIK), a global leader in the osteoarthritis pain management and regenerative solutions spaces focused on early...

ANIK : 14.90 (+0.34%)
Anika: Q4 Earnings Snapshot

Anika: Q4 Earnings Snapshot

ANIK : 14.90 (+0.34%)
Anika Reports Fourth Quarter and Full Year 2025 Financial Results

Met 2025 revenue and exceeded revised adjusted EBITDA; reaffirms 2026 revenue and sets adjusted EBITDA target Commercial Channel grew 22% and 15% for Q4 and full year, respectively Generated...

ANIK : 14.90 (+0.34%)
Anika To Present at the Canaccord Genuity 2026 Musculoskeletal Conference

BEDFORD, Mass., Feb. 18, 2026 (GLOBE NEWSWIRE) -- Anika Therapeutics, Inc. (NASDAQ: ANIK), a global joint preservation company in early intervention orthopedics, today announced that Steve Griffin,...

ANIK : 14.90 (+0.34%)
Anika to Issue Fourth Quarter and Year-End 2025 Financial Results on Thursday, February 26, 2026

BEDFORD, Mass., Feb. 12, 2026 (GLOBE NEWSWIRE) -- Anika Therapeutics, Inc. (NASDAQ: ANIK), a global joint preservation company in early intervention orthopedics, announced today that it will issue...

ANIK : 14.90 (+0.34%)

Business Summary

Anika Therapeutics, Inc. is a global, integrated orthopedic medicines company based in Bedford, Massachusetts. Anika is committed to improving the lives of patients with degenerative orthopedic diseases and traumatic conditions with clinically meaningful therapies along the continuum of care, from palliative...

See More

Key Turning Points

3rd Resistance Point 17.12
2nd Resistance Point 16.13
1st Resistance Point 15.49
Last Price 14.90
1st Support Level 13.86
2nd Support Level 12.87
3rd Support Level 12.23

See More

52-Week High 16.24
Last Price 14.90
Fibonacci 61.8% 13.04
Fibonacci 50% 12.06
Fibonacci 38.2% 11.07
52-Week Low 7.87

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.